11 Sept 2026 - ASX-listed drug developer draws down remaining Tranche 4 from Convertible Note Facility, boosting working capital for key osteoarthritis study.
11 Sept 2026 - Forty-two diamond core holes completed at Golden Gate, targeting significant gold and tungsten extensions, with assay results for 39 holes pending.